73 related articles for article (PubMed ID: 3243661)
1. Serum protein binding of penbutolol in patients with hepatic cirrhosis.
Aguirre C; Calvo R; Rodríguez Sasiaín JM
Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):566-9. PubMed ID: 3243661
[TBL] [Abstract][Full Text] [Related]
2. Unchanged protein binding of penbutolol in renal insufficiency: a possible role of carbamylation.
Aguirre C; Calvo R; Rodriguez-Sasiain JM
Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):31-4. PubMed ID: 8444514
[TBL] [Abstract][Full Text] [Related]
3. Serum binding of ketoconazole in health and disease.
Martínez-Jordá R; Rodriguez-Sasiain JM; Suárez E; Calvo R
Int J Clin Pharmacol Res; 1990; 10(5):271-6. PubMed ID: 2079384
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of penbutolol in healthy and cancer subjects: role of altered protein binding.
Aguirre C; Trocóniz IF; Valdivieso A; Jiménez RM; González JP; Calvo R; Rodríguez-Sasiaín JM
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):53-72. PubMed ID: 8733828
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
García-Morillas M; Gil-Extremera B; Caracuel-Ruiz MD
Int J Clin Pharmacol Res; 1984; 4(5):327-33. PubMed ID: 6519849
[TBL] [Abstract][Full Text] [Related]
6. Protein binding studies of furosemide and penbutolol.
Gottschalk R; Sistovaris N
Arzneimittelforschung; 1985; 35(6):899-902. PubMed ID: 4026914
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of serum protein binding of felodipine.
Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
[TBL] [Abstract][Full Text] [Related]
8. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
9. Plasma protein binding of zolpidem in liver and renal insufficiency.
Pacifici GM; Viani A; Rizzo G; Carrai M; Ganansia J; Bianchetti G; Morselli PL
Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):439-43. PubMed ID: 3198298
[TBL] [Abstract][Full Text] [Related]
10. Plasma protein binding of etomidate in different age groups and in patients with chronic respiratory insufficiency.
Carlos R; Calvo R; Erill S
Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):171-4. PubMed ID: 7263105
[TBL] [Abstract][Full Text] [Related]
11. Plasma protein binding of penbutolol in pregnancy.
Aquirre C; Rodriguez-Sasiain JM; Navajas P; Calvo R
Eur J Drug Metab Pharmacokinet; 1988; 13(1):23-6. PubMed ID: 3396610
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin levels in patients with nonalcoholic chronic liver disease.
Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
[TBL] [Abstract][Full Text] [Related]
13. Decrease in penbutolol protein binding as a consequence of treatment with some alkylating agents.
Aguirre C; Rodríguez-Sasiain JM; Calvo R
Cancer Chemother Pharmacol; 1994; 34(1):86-8. PubMed ID: 8174208
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral penbutolol on renal haemodynamics of hypertensive patients with renal insufficiency.
Bailey RR; Carlson RV; Walker RJ; Swainson CP
N Z Med J; 1985 Aug; 98(785):683-5. PubMed ID: 3863029
[TBL] [Abstract][Full Text] [Related]
15. Decrease in penbutolol central response as a cause of changes in its serum protein binding.
Martínez Jordá R; Aguirre C; Calvo R; Rodríguez-Sasiaín JM; Erill S
J Pharm Pharmacol; 1990 Mar; 42(3):164-6. PubMed ID: 1974610
[TBL] [Abstract][Full Text] [Related]
16. Effect of penbutolol on lidocaine kinetics.
Ochs HR; Skanderra D; Abernethy DR; Greenblatt DJ
Arzneimittelforschung; 1983; 33(12):1680-1. PubMed ID: 6686773
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective serum protein binding of ketoprofen in liver diseases.
Sakai T; Maruyama T; Sako T; Ahmed S; Zuidema X; Fujiyama S; Otagiri M
Enantiomer; 1999; 4(5):477-82. PubMed ID: 10586515
[TBL] [Abstract][Full Text] [Related]
18. Enhanced renal clearance of uric acid in hepatic cirrhosis.
Higuchi T; Nakamura T; Uchino H
Isr J Med Sci; 1981 Nov; 17(11):1015-8. PubMed ID: 7319788
[TBL] [Abstract][Full Text] [Related]
19. Protein binding of itraconazole and fluconazole in patients with cancer.
Arredondo G; Calvo R; Marcos F; Martínez-Jordá R; Suarez E
Int J Clin Pharmacol Ther; 1995 Aug; 33(8):449-52. PubMed ID: 8556224
[TBL] [Abstract][Full Text] [Related]
20. Penbutolol Pharmacokinetics: the influence of concomitant administration of cimetidine.
Spahn H; Kirch W; Hajdu P; Mutschler E; Ohnhaus EE
Eur J Clin Pharmacol; 1986; 29(5):555-60. PubMed ID: 3956561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
